The Risk of Breast Carcinoma with Interferon Plus Ribavarin Therapy during Treatment of Chronic Hepatitis C Virus Infection-A Case Report | Zendy

AI Assistant Blog Pricing

Open Access

The Risk of Breast Carcinoma with Interferon Plus Ribavarin Therapy during Treatment of Chronic Hepatitis C Virus Infection-A Case Report

Author(s) -

Manuela Stoicescu

Publication year - 2013

Publication title -

journal of developing drugs

Language(s) - English

Resource type - Journals

ISSN - 2329-6631

DOI - 10.4172/2329-6631.1000102

Subject(s) - medicine , interferon , hepatocellular carcinoma , breast carcinoma , chronic hepatitis , hepatitis c virus , virus , virology , oncology , immunology , breast cancer , cancer

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Empowering knowledge with every search

About

About Careers Publisher Partners Contact Us

Learn

FAQs Blog Terms of Use Privacy Policy

Discover

Explore

Copyright Knowledge E © 2025. All Rights Reserved.